Bone scintigraphy screening in stage I-II breast cancer: Is it cost effective?

被引：0
|
作者：
Wikenheiser, KA [1 ]
Silberstein, EB [1 ]
机构：
[1] UNIV CINCINNATI, MED CTR, CINCINNATI, OH 45267 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 1996年 / 63卷 / 01期
关键词：
radionuclide imaging; breast neoplasms; bone neoplasms; cost-benefit analysis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraph should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
引用
收藏
页码：43 / 47
页数：5
相关论文
共 50 条
  • [31] Cytokeratin-positive cells in bone marrow of women with FIGO stage I-II cervical cancer
    Janni, W
    Braun, S
    Rack, B
    Strobl, B
    Thieleke, W
    Schindlbeck, C
    Hepp, F
    Gerber, B
    Sommer, H
    Friese, K
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2003, 63 (07) : 669 - 676
  • [32] Socioeconomic status as an independent prognostic factor in node negative, stage I-II breast cancer patients
    Zeichner-Gancz, I.
    Munoz-Gonzalez, D. E.
    Perez Sanchez, V. M.
    Castillero, C.
    Ramirez-Ugalde, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Predictive model of axillary lymph node involvement (ALNI) In stage I-II breast cancer (BC)
    Martin, C
    Cutuli, B
    Velten, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S116 - S116
  • [34] Factors associated with the addition of radiation therapy after mastectomy in women with stage I-II breast cancer
    Punglia, RS
    Hughes, M
    Edge, S
    Theriault, R
    Bookman, M
    Burak, W
    Ottensen, R
    Niland, J
    Weeks, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S142 - S143
  • [35] Incidence and time of occurrence of regional recurrence in stage I-II breast cancer:: Value of adjuvant irradiation
    Fodor, J
    Tóth, J
    Major, T
    Polgár, C
    Németh, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02): : 281 - 287
  • [36] IS SCREENING FOR BREAST-CANCER COST-EFFECTIVE
    MUSHLIN, AI
    FINTOR, L
    CANCER, 1992, 69 (07) : 1957 - 1962
  • [37] Is mass screening for breast cancer cost-effective?
    deKoning, HJ
    Coebergh, JWW
    vanDongen, JA
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1835 - 1839
  • [38] Breast cancer screening; cost-effective in practice?
    de Koning, HJ
    EUROPEAN JOURNAL OF RADIOLOGY, 2000, 33 (01) : 32 - 37
  • [39] Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer
    van Loon, J. W. L.
    Smeele, L. E.
    Hilgers, F. J. M.
    van den Brekel, M. W. M.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (01) : 175 - 183
  • [40] Concurrent Chemoradiotherapy (CCRT) for Stage I-II Esophageal Cancer Patients
    Fukada, J.
    Kumabe, A.
    Kota, R.
    Koike, N.
    Toyama, H.
    Shiraishi, Y.
    Kitagawa, Y.
    Shigematsu, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E27 - E27
12345